Dias Tabata Z, Passini Renato, Tedesco Ricardo P, Lajos Giuliane J, Rehder Patricia M, Nomura Marcelo L, Costa Maria L, Oliveira Paulo F, Sousa Maria H, Cecatti Jose G
Department of Obstetrics and Gynecology, School of Medical Sciences, University of Campinas, Campinas, Brazil.
Department of Obstetrics and Gynecology, Jundiaí Medical School, Jundiaí, Brazil.
Int J Gynaecol Obstet. 2017 Nov;139(2):222-229. doi: 10.1002/ijgo.12297. Epub 2017 Sep 9.
To evaluate prenatal corticosteroid use in women experiencing spontaneous preterm labor and preterm delivery.
The present cross-sectional multicenter study analyzed interview data from patients attending 20 hospitals in Brazil owing to preterm delivery between April 1, 2011 and July 30, 2012. Patients were stratified based on preterm delivery occurring before 34 weeks or at 34-36 weeks of pregnancy, and the frequency of prenatal corticosteroid use at admission was compared. Prenatal corticosteroid use, sociodemographic data, obstetric characteristics, and neonatal outcomes were examined.
There were 1455 preterm deliveries included in the present study; 527 (36.2%) occurred before 34 weeks of pregnancy and prenatal corticosteroids were used in 285 (54.1%) of these pregnancies. Among neonates delivered at 32-33 weeks, prenatal corticosteroid use was associated with lower pneumonia (P=0.026) and mortality (P=0.029) rates. Among neonates delivered at 34-36 weeks, prenatal corticosteroid use was associated with longer neonatal hospital admission (P<0.001), and an increased incidence of 5-minute Apgar scores below 7 (P=0.010), endotracheal intubation (P=0.042), surfactant use (P=0.006), neonatal morbidities (P=0.048), respiratory distress (P=0.048), and intraventricular hemorrhage (P=0.023).
Preterm labor and late preterm delivery were associated with worse neonatal outcomes following prenatal corticosteroids. This could reflect a sub-optimal interval between administration and delivery.
评估在发生自然早产和早产分娩的女性中使用产前糖皮质激素的情况。
本横断面多中心研究分析了2011年4月1日至2012年7月30日期间因早产在巴西20家医院就诊的患者的访谈数据。根据妊娠34周前或34 - 36周发生的早产对患者进行分层,并比较入院时产前糖皮质激素的使用频率。对产前糖皮质激素的使用、社会人口统计学数据、产科特征和新生儿结局进行了检查。
本研究纳入了1455例早产分娩;527例(36.2%)发生在妊娠34周前,其中285例(54.1%)的这些妊娠使用了产前糖皮质激素。在32 - 33周分娩的新生儿中,使用产前糖皮质激素与较低的肺炎发生率(P = 0.026)和死亡率(P = 0.029)相关。在34 - 36周分娩的新生儿中,使用产前糖皮质激素与新生儿住院时间延长(P < 0.001)、5分钟阿氏评分低于7分的发生率增加(P = 0.010)、气管插管(P = 0.042)、使用表面活性剂(P = 0.006)、新生儿发病率(P = 0.048)、呼吸窘迫(P = 0.048)和脑室内出血(P = 0.023)相关。
早产和晚期早产与产前使用糖皮质激素后较差的新生儿结局相关。这可能反映了给药与分娩之间的间隔不理想。